THURSDAY, Jan. 2, 2025 (HealthDay News) -- Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy ...
Acupuncture shows promise in reducing overactive bladder symptoms and stress incontinence ... Warning signs requiring medical attention include frequent urination, pain during urination, or inability ...
[19] The effective dose is found by titration of the medication until symptoms are relieved ... better medications are available for the overactive bladder. With the recent approval of tolterodine ...